Representative picture | Photo Credit: Reuters
However, a slightly stronger dollar, coupled with FII outflows, prevented sharper beneficial properties within the native unit, based on foreign exchange merchants. They added that the markets are awaiting the Reserve Bank of India’s (RBI’s) Monetary Policy Committee resolution, which might be introduced on Wednesday (October 1, 2025).
At the interbank overseas change, the rupee opened at 88.73 in opposition to the U.S. greenback earlier than inching as much as 88.72, larger by 3 paise from its earlier shut.
Rupee consolidated in a slim vary and settled decrease by 3 paise at 88.75 in opposition to the dollar on Monday (September 29, 2025).
“FPIs continue to be sellers in equity markets taking rupee down whenever it rises and with no further news on the India-US trade treaty, markets are awaiting the RBI’s policy decision on Wednesday (October 1, 2025),” Anil Kumar Bhansali, Head of Treasury and Executive Director, Finrex Treasury Advisors LLP, stated.
The RBI assembly is happening in opposition to the backdrop of ongoing geopolitical tensions and the U.S. imposing 50% tariffs on Indian shipments.
Meanwhile, the greenback index, which gauges the dollar’s energy in opposition to a basket of six currencies, was buying and selling at 97.94, larger by 0.04%.
Brent crude, the worldwide oil benchmark, was buying and selling 0.79% decrease at $67.43 per barrel in futures commerce.
“Brent fell on increased supply from Kurdistan exports to Turkey, with OPEC+ preparing for another rise in production in November and the possible U.S. shutdown also reducing the consumption,” Mr. Bhansali stated.
On the home fairness market entrance, markets bounced again in early commerce with the Sensex climbing 312.88 factors to 80,677.82 and the Nifty rising 96.9 factors to 24,731.80.
Foreign Institutional Investors offloaded equities price ₹2,831.59 crore on Monday (September 29, 2025), based on change information.
Meanwhile, the U.S. has introduced the imposition of a 100% tariff on branded or patented medication coming into the U.S. from October 1, aside from pharmaceutical corporations constructing manufacturing vegetation within the U.S.
The exemption covers initiatives the place development has began, together with websites which have damaged floor or are below development.
Published – September 30, 2025 10:17 am IST

